Free Trial
Earnings Season Is Here. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion
OTCMKTS:WUXAY

WuXi AppTec Earnings Date & Estimates

WuXi AppTec logo
$23.71 0.00 (0.00%)
As of 10/23/2026 03:56 PM Eastern

WuXi AppTec is estimated to report earnings on Monday, October 26, 2026, after market closes.

Upcoming Earnings Announcement

Announcement Date
Time
After Market Closes

What Analysts Expect from WuXi AppTec

WuXi AppTec is expected to post earnings of $0.4377 per share on revenue of $2.39 billion. WuXi AppTec last reported on April 27, 2026, posting $0.23 per share and beating the $0.1773 consensus estimate.

Consensus Estimates

Consensus EPS
$0.4377
Expected Revenue
$2.39 billion

Recent Track Record

Last Reported
Q1 2026
Last Quarter EPS
$0.23 (Beat by +$0.0527)
Last Quarter Revenue
$1.82 billion

WuXi AppTec Earnings FAQ

WuXi AppTec (OTCMKTS:WUXAY) is estimated to report earnings on Monday, October 26, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect WuXi AppTec to post earnings of $0.4377 per share for the quarter.

The consensus revenue estimate for WuXi AppTec is $2.39 billion for the quarter.

WuXi AppTec Earnings Headlines

WuXi AppTec (WUXAY) Expected to Post Quarterly Earnings on Monday
WuXi AppTec (OTCMKTS:WUXAY) Sees Large Volume Increase - Here's Why
“The crisis that’s emerging now is just the tip of the iceberg,” says Dr. Martin D. Weiss, who has made shocking and accurate predictions for 55 years
Dr. Martin D. Weiss, who predicted the Dot-Com collapse and the failures of Fannie Mae, Bear Stearns, and Lehman Brothers, is warning of a developing financial crisis. The New York Times has credited him as among the first to see the dangers ahead, and Forbes dubbed him Mr. Independence. He says this emerging situation could trigger a chain reaction across banks and markets. Watch his free video breakdown and see the five steps he outlines for investors.tc pixel
See More WuXi AppTec Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like WuXi AppTec? Sign up for Earnings360's daily newsletter to receive timely earnings updates on WuXi AppTec and other key companies, straight to your email.

About WuXi AppTec

WuXi AppTec (OTCMKTS:WUXAY) is a global pharmaceutical and biotechnology services company that provides contract research, development and manufacturing services. The company supports drug developers throughout the product life cycle, from early-stage discovery and laboratory testing through clinical development and commercial production.

Its offerings include medicinal and synthetic chemistry, biology research, preclinical and clinical testing, regulatory support, pharmaceutical manufacturing, and the development and manufacturing of advanced therapies. WuXi AppTec serves customers developing small-molecule drugs, biologics, cell and gene therapies, and other healthcare products.

Founded in 2000, the company has built an international operating network with facilities and laboratories in China, the United States, Europe and other locations. WuXi AppTec was co-founded by Dr. Ge Li, who has served as the company’s chairman and chief executive officer. Its customers include pharmaceutical, biotechnology and medical-device companies seeking outsourced research and manufacturing capabilities.

View WuXi AppTec Profile